About Axis Clinicals Limited
Data last updated: 11 January 2026
Axis Clinicals Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 17 February 2007, the company has been in operation for over 19 years.
Registered with ROC Hyderabad under CIN U40100TG2007PLC052813.
Capital: an authorised share capital of ₹183.33 Cr and a paid-up capital of ₹180.36 Cr. Formerly known as Penaka Holdings Private Limited and Penaka Life Sciences Private Limited. It is led by directors including Lakshmi Vara Koka and Jayachandra Reddy Atluri.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 1 – 121/1 Sy. Nos.66 (Part) & 67 (Part) Miyapur Serilingampally, Hyderabad, Telangana, India – 500049.
As per the financials filed for FY 2025, the company reported a revenue of ₹386.63 Cr, a decline of 6% compared to the previous year.
The company has a workforce of approximately 528 employees as per the latest available data.
The company is associated with 1 brand - Axis Clinicals. As per MCA filings, the company has open charges of ₹1,256.45 Cr and satisfied charges of ₹517.22 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website axisclinicals.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered Address1 – 121/1 Sy. Nos.66 (Part) & 67 (Part) Miyapur Serilingampally, Hyderabad, Telangana, India – 500049
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Axis Clinicals Limited
Axis Clinicals Limited has undergone 3 name changes throughout its history. The company was previously known as Penaka Holdings Private Limited, Penaka Life Sciences Private Limited, and Axis Clinicals Private Limited. The current legal name is Axis Clinicals Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Axis Clinicals Limited | Current |
| Penaka Holdings Private Limited | Previous |
| Penaka Life Sciences Private Limited | Previous |
| Axis Clinicals Private Limited | Previous |
CIN History of Axis Clinicals Limited
Axis Clinicals Limited has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U73100TG2007PLC052813, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2007PLC052813 | Current |
| U40100TG2007PLC052813 | Previous |
| U67120TG2007PLC052813 | Previous |
| U67120AP2007PTC052813 | Previous |
| U67120AP2007PLC052813 | Previous |
Associated Brands with Axis Clinicals Limited
Axis Clinicals Limited operates one associated brand: AXIS Clinicals. These brands represent Axis Clinicals Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides contract research organization services for clinical trials worldwide. | axisclinicals.com |
Competitors & Alternatives of Axis Clinicals Limited
Brands and companies operating in the same space as Axis Clinicals Limited include Emmes, Syneos Health, ClinChoice and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Emmes
|
Outsourced contract research organization services are provided to clients. | United States | 1977 |
Syneos Health
|
CRO clinical development services are provided by Syneos Health. | Raleigh, United States, United States | 1984 |
ClinChoice
|
CRO focused on data management, regulatory affairs and consulting services | Fort Washington, United States, United States | 1995 |
Veristat
|
Clinical trials and regulatory submissions are supported as a CRO. | Southborough, United States, United States | 1994 |
Parexel
|
Full-service clinical research organization services are provided globally by Parexel. | Waltham, United States, United States | 1983 |
hVIVO
|
Provider of cell based assays, field trial, and molecular services for biopharma sector | London, United Kingdom, United Kingdom | 1998 |
Medelis WCCT Global
|
Full-service CRO expertise in influenza and oncology research is offered. | Cypress, United States, United States | 1998 |
Celgene
|
Therapies for cancer and inflammatory diseases are developed. | Summit, United States, United States | 1986 |
Business Activity of Axis Clinicals Limited
Axis Clinicals Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including architecture, engineering activities, technical testing and analysis activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities | ********* |
Board of Directors of Axis Clinicals Limited
Axis Clinicals Limited is currently managed by 8 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Lakshmi Vara Koka
Also directs:
Trident Chemphar Limited, Shreas Industries Limited
|
Additional Director | 30 Oct 2024 | 1 Years 8 Months | Current |
|
Jayachandra Reddy Atluri
Also directs:
Clini Vigil Pharma Solutions Private Limited
|
Whole-Time Director | 06 Jul 2009 | 17 Years 0 Months | Current |
| Panibhushan Reddy Bonga | Whole-Time Director | 06 Jul 2009 | 17 Years 0 Months | Current |
| Mallikarjuna Reddy Kantabathuni | Director | 06 Jul 2009 | 17 Years 0 Months | Current |
|
China Venka Reddy Kotta
Also directs:
Trident Chemphar Limited, Shreas Industries Limited, C V Reddy K & Associates Private Limited and 1 more
|
Director | 07 Apr 2025 | 1 Years 3 Months | Current |
| Naga Venkata Kesavarapu | Director | 07 Apr 2025 | 1 Years 3 Months | Current |
Financials of Axis Clinicals Limited FY 2025 filings available
Axis Clinicals Limited reported revenue of ₹386.63 Cr (down 6% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Axis Clinicals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2025 | Others | ₹40 Cr | Open |
| 10 Apr 2024 | Others | ₹175 Cr | Open |
| 13 Dec 2023 | Others | ₹100 Cr | Open |
| 13 Dec 2023 | Axis Bank Limited | ₹31 Lakh | Open |
| 31 Mar 2021 | Sbicap Trustee Company Limited | ₹911.9 Cr | Open |
Total charge records: 34 View all charges
Employees and EPFO Compliance at Axis Clinicals Limited
View historical data on people associated with Axis Clinicals Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Axis Clinicals Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Axis Clinicals Limited
GSTIN & GST Filing Data of Axis Clinicals Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Axis Clinicals Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Axis Clinicals Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Axis Clinicals Limited
MSME Payment Delays by Axis Clinicals Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Axis Clinicals Limited
Subsidiaries & Group Companies of Axis Clinicals Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Axis Clinicals Limited with ownership details.
MCA Filings & Documents of Axis Clinicals Limited
MCA Filings & Documents of Axis Clinicals Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Axis Clinicals Limited
Recent News on Axis Clinicals Limited
Frequently Asked Questions about Axis Clinicals Limited
Axis Clinicals Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 17 February 2007 (19+ years old) and is registered under CIN U73100TG2007PLC052813. The company has 528 employees.
Axis Clinicals Limited reported revenue of ₹386.63 Cr for FY 2025 (down 6.00% YoY).
The current directors of Axis Clinicals Limited are:
The primary industry of Axis Clinicals Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.
Axis Clinicals Limited can be reached at the registered office: 1 – 1211 Sy. Nos.66 Part & 67 Part Miyapur Serilingampally, Hyderabad, Telangana, India – 500049, or through the website axisclinicals.com.
The authorised capital is ₹183.33 Cr, and the paid-up capital is ₹180.36 Cr.